Highlights BCAL Diagnostics Limited

Equities

BDX

AU0000160921

Market Closed - Australian S.E. Other stock markets 01:31:46 2024-05-16 EDT			5-day change	1st Jan Change
0.11 ^AUD	-4.35%		+18.28%	+11.11%

03-06	BCAL Diagnostics Appoints CEO	MT
02-20	BCAL Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BCAL Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-20	CI
BCAL Diagnostics Joins Forces to Conduct Breast Cancer Blood Test Study in India	11-29	MT
BCAL Diagnostics Secures AU$3 Million R&D Tax Rebate for Fiscal Year 2023; Shares Fall 5%	11-13	MT
BCAL Diagnostics Files for Additional Australian Patent Application	11-06	MT
BCAL Diagnostics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-29	CI
Bcal Diagnostics Limited Opens New Laboratory in Sydney	23-05-04	CI
BCAL Diagnostics Opens Laboratory in Sydney	23-05-03	MT
BCAL Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-23	CI
BCAL Diagnostics Limited Announces Establishment of Development & Clinical Service Laboratory	22-10-24	CI
BCAL Diagnostics Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-29	CI
BCAL Diagnostics Limited Enters US Product Development Agreement with Precion Inc	22-06-27	CI
BCAL Diagnostics : Shareholder Newsletter	22-03-24	PU
BCAL Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-17	CI
Bcal Diagnostics Limited Provides Additional Information on Recent Analysis to Distinguish Between Blood Samples of Breast Cancer Patients and Normal Control Samples	22-02-07	CI
Bcal Diagnostics Limited Announces Recent Analysis Significantly Improves Commercial Prospects	22-02-06	CI
BCAL Diagnostics Limited Announces Strong Cohort 4 Testing Data Demonstrates Value of BCAL Test	21-11-02	CI
BCAL Diagnostics Limited Commences Collecting Samples for the First Stage of Its Australian Clinical Program	21-09-02	CI
BCAL Diagnostics Limited Announces Earnings Results for the Year Ended June 30, 2021	21-08-30	CI
BCAL Diagnostics Limited Executes Product Development Agreement Izon Science Limited	21-08-16	CI
BCAL Diagnostics Limited in Collaboration with GenesisCare Clinical CRO, Expanding Clinical Study Centres to Al States of Australia	21-08-16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights BCAL Diagnostics Limited

Equities

BDX

AU0000160921

Highlights

Filters